FLAG Regimen and Bortezomib: A Study of Eight Cases with Relapsed Leukaemia
Historically, relapsed and refractory Acute Lymphoblastic Leukaemia (ALL) and Acute Myeloid Leukaemia (AML) have been associated with a dismal prognosis. Relapse-refractory ALL is associated with cure rates of <10% in adults and 30% in the paediatric population. Similarly, the five-year survival...
Main Authors: | Afaq Khan, Reshma Roshan, Sajad Ahmed Geelani, Santosh Govind Rathod, Aakash Chozakade, Javid Rasool Bhat, J Sherook |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2023-12-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/18873/62236_CE[Ra1]_F(IS)_QC&PAT.(SD_RN_IS)_PF1(AKA_OM)_PFA(KM)_PN(OM).pdf |
Similar Items
-
THE INCIDENCE OF LEUKAEMIA IN KYRGYZSTAN IN CHILDREN UNDER 5 YEARS
by: A.A. USENOVA
Published: (2018-03-01) -
Classification of Acute Leukaemia based on Blast Morphology, Cytochemistry and Flow Cytometry
by: P Jubit Paulose, et al.
Published: (2023-02-01) -
REMISSION RATE OF PRE-B ALL (ACUTE LYMPHOBLASTIC LEUKEMIA) AFTER INDUCTION CHEMOTHERAPY FOLLOWING UNITED KINGDOM ACUTE LYMPHOBLASTIC LEUKAEMIA 2011 (UKALL 2011) TRIAL PROTOCOL
by: Hafiz Muhammad Murtaza, et al.
Published: (2021-04-01) -
Targeted Therapy in Acute Lymphoblastic Leukaemia
by: Ross Salvaris, et al.
Published: (2021-07-01) -
Acute leukemia in pregnancy: a single institutional experience with 21 cases at 10 years and a review of the literature
by: Dengqin Zhu, et al.
Published: (2021-01-01)